The latest report published by IMARC Group, titled “Single-Use Bioprocessing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028”, offers a comprehensive analysis of the industry, which comprises insights on single-use bioprocessing market growth. The report also includes competitor and regional analysis, and contemporary advancements in the global market.

The global single-use bioprocessing market size reached US$ 13.6 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 37.7 Billion by 2028, exhibiting a growth rate (CAGR) of 19.8% during 2023-2028.

Single-Use Bioprocessing (SUB) is a method in the biopharmaceutical industry that utilizes disposable materials and equipment to produce biological products. These one-time-use technologies encompass components such as bioreactors, mixers, bags, filters, tubing, and connectors, which replace traditional stainless-steel counterparts. SUB systems are specifically designed to enhance process flexibility, reduce contamination risks, and reduce the time and costs associated with cleaning and sterilization. They are commonly used in developing, developing, and manufacturing vaccines, monoclonal antibodies, and other biologic therapeutics. As part of a broader trend towards streamlined and sustainable manufacturing, Single-Use Bioprocessing is increasingly adopted in life science organizations, pharmaceutical companies, and biotech startups, setting a new standard in process efficiency and safety.

Request to Get the Sample Report: https://www.imarcgroup.com/single-use-bioprocessing-market/requestsample

Market Trends:

The global Single-Use Bioprocessing market is exhibiting robust growth, propelled by the increasing demand for flexible and efficient manufacturing processes in the biopharmaceutical industry. The adoption of SUB enables rapid product development, scaling, and quicker market access, which is especially vital in response to urgent health challenges, including pandemics. Along with this, the reduction in cross-contamination risks and the adherence to stringent regulatory compliance contribute to market expansion. In addition, technological advancements leading to improved SUB system designs and capabilities further support this upward trajectory. The trend towards sustainability and eco-friendly practices is mirrored in the growing interest in recyclable and biodegradable single-use components. Apart from this, strategic alliances, investments in research and development, and the globalization of biopharmaceutical manufacturing are shaping the future of the SUB market. Furthermore, the rise in biosimilar production and the growing recognition of the economic advantages of Single-Use Bioprocessing are also integral to this vibrant market's continued growth and diversification.

View Full Report with TOC & List of Figure: https://www.imarcgroup.com/single-use-bioprocessing-market

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

• Applikon Biotechnology
• Boehringer Ingelheim
• Cesco Bioengineering Company
• Corning Inc.
• Danaher Corporation
• Entegris
• Eppendorf AG
• Finesse Solutions Inc.
• GE Healthcare
• Infors
• Merck Millipore
• Rentschler Biotechnologie
• Sartorius Stedim Biotech
• Thermo Fisher Scientific Inc.
• 3M Company

Single-Use Bioprocessing Market Segmentation:

Our report has categorized the market based on region, product type, application, end-use and end-user.

Product Type Insights:

• Media Bags and Containers
• Filtration Assemblies
• Single-Use Bioreactors
• Disposable Mixers
• Others

Application Insights:

• Filtration
• Storage
• Cell Culture
• Mixing
• Purification

End-Use Insights:

• Upstream
• Fermentation
• Downstream

End-User Insights:

• Biopharmaceutical Manufacturers
• Life Science R&D
• Others

Breakup by Region:

• North America (United States, Canada)
• Europe (Germany, France, United Kingdom, Italy, Spain, Others)
• Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)

Key highlights of the report:

• Market Performance (2017-2022)
• Market Outlook (2023-2028)
• Porter’s Five Forces Analysis
• Market Drivers and Success Factors
• SWOT Analysis
• Value Chain
• Comprehensive Mapping of the Competitive Landscape

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe:- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800